Literature DB >> 17038711

Prevention of diabetes.

Carl Heneghan, M Thompson, R Perera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038711      PMCID: PMC1602003          DOI: 10.1136/bmj.38996.709340.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Early detection of undiagnosed diabetes mellitus: a US perspective.

Authors:  M I Harris; R C Eastman
Journal:  Diabetes Metab Res Rev       Date:  2000 Jul-Aug       Impact factor: 4.876

Review 2.  Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.

Authors:  Richard W Nesto; David Bell; Robert O Bonow; Vivian Fonseca; Scott M Grundy; Edward S Horton; Martin Le Winter; Daniel Porte; Clay F Semenkovich; Sidney Smith; Lawrence H Young; Richard Kahn
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

3.  How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump?

Authors:  Victor M Montori; Jason W Busse; Gaieta Permanyer-Miralda; Ignacio Ferreira; Gordon H Guyatt
Journal:  ACP J Club       Date:  2005 Nov-Dec

4.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Authors:  H C Gerstein; S Yusuf; J Bosch; J Pogue; P Sheridan; N Dinccag; M Hanefeld; B Hoogwerf; M Laakso; V Mohan; J Shaw; B Zinman; R R Holman
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

5.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

9.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

Authors:  Jarl S Torgerson; Jonathan Hauptman; Mark N Boldrin; Lars Sjöström
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

  9 in total
  6 in total

1.  Prevention of diabetes: ethical consideration.

Authors:  Philipp Andreas Conradi
Journal:  BMJ       Date:  2006-10-28

2.  Prevention of diabetes: lifestyle and metformin are the way forward.

Authors:  John S Ashcroft
Journal:  BMJ       Date:  2006-10-28

3.  Motivational interviewing for modifying diabetes risk: a randomised controlled trial.

Authors:  Colin J Greaves; Andrew Middlebrooke; Lucy O'Loughlin; Sandra Holland; Jane Piper; Anna Steele; Tracy Gale; Fenella Hammerton; Mark Daly
Journal:  Br J Gen Pract       Date:  2008-08       Impact factor: 5.386

4.  Can type 2 diabetes be prevented in UK general practice? A lifestyle-change feasibility study (ISAIAH).

Authors:  Chris Barclay; Kimberley L Procter; Robert Glendenning; Peter Marsh; Jenny Freeman; Nigel Mathers
Journal:  Br J Gen Pract       Date:  2008-08       Impact factor: 5.386

Review 5.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

Review 6.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.

Authors:  Clare L Gillies; Keith R Abrams; Paul C Lambert; Nicola J Cooper; Alex J Sutton; Ron T Hsu; Kamlesh Khunti
Journal:  BMJ       Date:  2007-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.